iMedrix Diagnostics Corp.

iMedrix Diagnostics Corp. is a medical device company headquartered in Northern New Jersey specializing in mobile cardiac care solutions. The company develops and markets KardioScreen™, a US FDA 510(k)-cleared, medical-grade mobile 12/6-lead ECG system that enables real-time cardiac monitoring and diagnosis. KardioScreen™ is cloud-connected, fully digital, and designed for bedside and remote monitoring applications, allowing clinicians to diagnose and manage cardiac conditions within minutes. The platform serves hospitals, clinics, and care providers seeking portable, economical alternatives to traditional fixed ECG systems. iMedrix targets both acute care settings and remote/home-based monitoring environments. The company emphasizes patient-centric design, regulatory compliance (FDA 510(k) clearance), and accessibility of cardiac diagnostics through innovative digital technology.